Cargando…

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19

Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and severe microthrombi and microvascular obliterative disease. It is hypothesized that those patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Veronica, Bradley, Elisa A., Badagliacca, Roberto, Sabanayagam, Aarthi, Rajpal, Saurabh, Lastinger, Lauren T., Daniels, Curt J., Smith, J. Shaun, Benza, Raymond L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686637/
https://www.ncbi.nlm.nih.gov/pubmed/33282201
http://dx.doi.org/10.1177/2045894020970369

Ejemplares similares